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Abstract—Quantitative assessment of gait in patients with
Parkinson’s disease (PD) is an important step in addressing
motor symptoms and improving clinical management. Based
on the assessment of only 5 meters of gait with a single body-
fixed-sensor placed on the lower back, this study presents a
method for the identification of step-by-step kinematic
parameters in 14 healthy controls and in 28 patients at
early-to-moderate stages of idiopathic PD. Differences
between groups in step-by-step kinematic parameters were
evaluated to understand gait impairments in the PD group.
Moreover, a discriminant model between groups was built
from a subset of significant and independent parameters and
based on a 10-fold cross-validated model. The discriminant
model correctly classified a total of 89.5% participants with
four kinematic parameters. The sensitivity of the model was
95.8% and the specificity 78.6%. The results indicate that the
proposed method permitted to reasonably recognize idio-
pathic PD-associated gait from 5-m walking assessments.
This motivates further investigation on the clinical utility of
short episodes of gait assessment with body-fixed-sensors.













Parkinsońs disease (PD) is among the most common
neurodegenerative diseases in Europe, with an esti-
mated prevalence of 1.6% in populations above
65 years old. The incidence of PD rises with age and
imposes an annual burden on European healthcare
systems that approximately ranges between 2600 and
10,000 e per patient. Thus, as the population’s long-
evity increases, it is expected that PD will impose a
growing social and economic burden on societies.
Consequently, an increased use of healthcare resources
for PD over the following years is expected, which will
likely have a significant impact on social security and
healthcare systems.26
The degeneration of the basal ganglia and the loss of
dopaminergic innervations in PD can cause body
rigidity, resting tremor and postural instability.9
Moreover, they may compromise the speed, auto-
maticity and fluidity or smoothness of movements4;
reflected in symptoms such as bradykinesia and
hypokinesia.9 These deficits are frequently present
during gait in patients with PD and can be quantita-
tively and objectively assessed,4 providing information
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regarding the clinical status of the patient. The
assessment of gait is part of a widely used clinical
rating scale for PD (Unified Parkinson’s disease rating
scale, UPDRS)6 and is used to monitor and regulate
the effects of interventions such as medication, deep-
brain-stimulation (DBS) and rehabilitation.8 Further-
more, since motor impairments such as trunk rigidity
and gait dysfunction are often present at initial stages
of the disease, their assessment might lead to earlier
and improved diagnosis.9 Altogether, the valid
assessment of movement in patients with PD is an
important step in addressing motor symptoms and
improving clinical management.26
Altered movement patterns in patients with PD can
be detected by analyzing signals recorded with
accelerometers and gyroscopes, both integrated in a
single device that is located on the lower back.8 These
signals represent the overall motion pattern given the
proximity of the sensor to the center of mass. Their
processing enables the assessment of trunk stability,
balance control and fall risk.18 In addition, the analysis
of the recorded signals permits the identification of gait
events 11 and the extraction of spatio-temporal gait
parameters that are sensitive to patients with motor
symptoms of PD.5
Accelerometers and gyroscopes, in this context also
known as body-fixed-sensors (BFS), are small, light-
weight, low-cost sensors with good portability and
low-power consumption. Therefore, they are easily
applicable and enable the assessment of movement
patterns in a clinical setting; potentially enhancing
objectivity, sensitivity and reliability of clinical tests.9
BFS can be used for the assessment of short epi-
sodes of gait, which provide information (gait speed,
gait cycle time and stride velocity) that differs from
information based on the analysis of long episodes of
gait and might be relevant for clinical assessment.14
Moreover, these sensors may be easily applicable in
view of limited space and time requirements, and given
that physical limitations in some patients might be an
impediment to performing longer episodes.11 Finally,
in short gait tests, patients can be challenged to in-
crease their gait speed without causing fatigue. This
could have relevant clinical implications, since the
performance of gait at high-speed might be different
than at convenient speed.9,24
The relevance for PD of instrumented clinical
assessment of short episodes of gait has been sup-
ported in several studies.7,10,21 For instance, the gait
task evaluation of the Short Physical Performance
Battery (SPPB) protocol has been reported to be re-
lated to disability and PD severity.21 In addition,
spatio-temporal parameters derived from low-back
accelerometry of 10-m walking assessment resulted
sensitive to dopamine agonist treatment.7 The assess-
ment of short episodes of gait with BFS is also well
suited to study gait initiation, which can be affected in
patients with PD.10 It is therefore conceivable that
acceleration, steady-state and deceleration phases of
gait episodes are all informative in the assessment of
PD-related motor impairments.
To our knowledge, there are no published studies
reporting a phase-by-phase analysis of short episodes of
gait in patients with PD. Therefore, in this study, epi-
sodes of 5-m gait were assessed with a single BFS placed
on the lower back that integrated a triaxial accelerom-
eter and a triaxial gyroscope. This permitted to calculate
step-by-step kinematic parameters in patients with PD
at early-to-moderate stages and healthy control (HC)
subjects. Significantly different parameters between
groups were evaluated to understand gait impairments
in the PD group (PDg). Moreover, from a selection of
these parameters, a discriminant model between groups
was built. With this, we aim to recognize idiopathic PD-




This cross-sectional study was performed with 38
participants, 24 patients diagnosed with idiopathic PD
and 14 healthy controls, well matched for age and
gender (see Table 1). All participants were recruited
from the clinical ward and the outpatient clinic of the
Neurodegenerative Department from University
Hospital of Tübingen, Germany.
The Declaration of Helsinki was respected, local
ethical committee approval was obtained (Tübingen
140622) and all subjects provided informed written
consent for participation in the study and for publi-
cation of individual, anonymized data.
The participants were selected according to the
following inclusion criteria: (a) age between 40 and
85 years; (b) ability to walk 10 meters independently
and stand safely without walking aid; (c) absence of
any psychiatric problem; (d) absence of dyskinesia. All
participants underwent a clinical assessment which
included: medical history, medication intake and neu-
rological examination.
The participants of the PDg were diagnosed with
idiopathic PD according to the United Kingdom Brain
Bank Society criteria, in stage 1 to 2.5 (medication
ON) of the Hoehn & Yahr scale and with a minimum
score of 25 points on the Mini Mental State Exami-
nation score. They did not present any other neuro-
logical disease. Six subjects with PD (25%) had
undergone a DBS operation. All the patients were re-
cruited in their regular ON medication state. The
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medication ON condition was defined as a time period
of 30 min to 3 h after the intake of the usual dose of
dopaminergic medication and considering each par-
ticipant’s perception of having a ‘‘Good On Phase’’.
The participants of the control group had no neuro-
logical disease and no relevant intellectual deficits.
An overview of demographic and clinical data is
presented in Table 1.
Protocol
All subjects, wearing their own shoes, walked a 5
meters long track after an acoustic start signal. The
track was demarcated by four templates of adult-sized
footprints, two attached to the floor at the start posi-
tion and two at the end position of the track. At the
beginning of each trial the subjects stood over the start
footprints for at least 3 s. After an acoustic signal, the
subjects started to walk the 5-m track. The trial ended
when the subjects reached the end, placing their shoes
on the footprint templates. Afterwards, the subjects
stood still for 3 s before repeating the trial. Two trials
were performed at self-selected gait speed (SS) and one
trial as fast as possible (FS).
Instrumentation
The system consisted of a BFS (DynaPort Hybrid,
McRoberts), a remote control and a portable com-
puter on which the DynaPort McRoberts software was
installed. The three were synchronized via Bluetooth.
The sensor includes a triaxial accelerometer and a tri-
axial gyroscope, storing data at a sampling rate of 100
samples/s. The accelerometer has a resolution of 1 mg
(0.0981 m/s2) and is a DC type sensor, sensitive to
gravity.
The sensor was inserted in an elastic belt, placed
around the waist so that the sensor was positioned at
the level of the lowest lumbar vertebra (L5). Then, the
software was activated and this initiated data collec-
tion. At the beginning and end of each trial an acoustic
signal was manually triggered with the remote control
and stored.
In addition, two BFS (DynaPort MiniMod McRo-
berts) were attached to the lateral sides of both heels in
22 patients with PD. These BFS include a DC type
triaxial accelerometer with a sample rate of 100 sam-
ples/s and a resolution of 1 mg (0.0981 m/s2).
Data acquisition was synchronized for all the col-
lected signals using an impulse that was transferred to
each of the systems.
Calculation of Kinematic Parameters
Velocity and displacement (Figs. 1, 2) in the ante-
rior-posterior direction (AP) were calculated from the
raw acceleration and angular velocity signals recorded
on the low-back, including the pre and post standing
phases.27 Further details of these calculations are
found in the Appendix 1 of supplementary material.
TABLE 1. Demographic and clinical data presented as mean 6 standard deviation for the parametric data and median [range] for
the non-parametric data, marked with *. In the case of gender, the data is presented as a number of females and (the percentage of










Leg length, from waist to the floor [cm] * 104.3 [97 - 121] 107 [58 - 116] 1
Grip strength, average for both hands [kg] 33.2 ± 10.1 38.4 ± 10.8 0.14
Grip strength, absolute difference between hands [kg] * 3.5 [0 - 23] 3 [0 - 5.5] 0.14
9.4±1.7]sraey[sisongaidecnis,notarudesaesiD 222-222 222-222
Disease duraton, since first symptoms [years] 8.8 ± 5.13 222-222 222-222
]5.2-1[2*)5-1(erocsrhaY&heoH 222-222 222-222
]03-52[68.82*)03-1(ESMM 222-222 222-222
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Phases
The ‘‘start of movement’’ was defined as the first
instant at which the AP velocity exceeded 30% of the
maximal AP velocity; whereas the ‘‘end of movement’’
was defined as the last instant at which the AP velocity
exceeded 20% of the maximal AP velocity (for the SS
condition) and 15% of the maximal AP velocity (for
the FS condition). The low-back acceleration in the
vertical direction (VT) was low-pass filtered with a bi-
directional fourth order filter and a cut-off frequency
of 3.5 Hz. Subsequently, the first heel-strike was de-
fined as the instant of the first peak after the ‘‘start of
movement’’. With the aim to automatically segment
the signal delimited by the ‘‘start’’ and ‘‘end of
movement’’ in step cycles, a template-match method 11
was applied to the low-back raw AP acceleration sig-
nal. Further details of this method are found in the
Appendix 2 of supplementary material.
The performance of the algorithm was tested over
data from 22 subjects of the PDg. Likewise calculated
in previous work, this was tested by comparing abso-
lute average differences within trials and across sub-
jects in stride duration between estimates obtained
from the application of the algorithm to low-back
accelerometry and estimates derived from heel
accelerometry (see Appendix 2 of supplementary
material).
The following gait phases were determined:
(1) Gait phase delimited between the ‘‘start’’ and
the ‘‘end of movement’’.
(2) From the acoustic signal to the ‘‘start of
movement’’.







Between the ‘‘start’’ and ‘‘end of movement’’, the
average gait speed of the trial was calculated as the
ratio of displacement and duration. In addition, the
number of steps was counted. The corrected displace-
ment, angular velocity and acceleration signals were
used to calculate kinematic parameters (Figs. 1, 2).




Step LastStep Pre-lastFrom acousc signal 
to “start of 
movement”
Step 3Step 2
From acousc signal 
to first heel-strike
Gait phase between “start” and “end of movement”
Step Middle
FIGURE 1. Typical example of forward velocity signal (in AP direction), forward displacement signal, acceleration signals in the
three axes and angular velocity signals in the three planes from a healthy control subject.
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(a) Duration.
(b) Forward displacement (AP).
(c) Range of forward velocity (AP).
(d) Root-mean-squared (RMS) value (variability
around the mean) of Acceleration VT.
(e) RMS of Acceleration ML
(medio-lateral direction).
(f) RMS of Acceleration AP.
(g) RMS of Angular velocity around VT axis.
(h) RMS of Angular velocity around ML axis.
(i) RMS of Angular velocity around AP axis.
Furthermore, the mean values across steps were cal-
culated for all the parameters. Subsequently, kinematic
parameters for each of the gait phases were calculated
relative to the mean value across steps (denoted as
‘‘relative’’). As a result, for both conditions (SS and FS),
160 kinematic parameters were obtained (Tables 2, 3).
All calculations were performed with a custom
Matlab program (version 7.10.0. Natwick, Mas-
sachusetts: The MathWorks Inc., R2010b).
Statistical Analysis
The Shapiro–Wilk test (for platykurtic samples) and
Shapiro–Francia test (for leptokurtic samples) were
implemented in Matlab to test normality of data dis-
tribution. Accordingly, unpaired t-tests and Wilcoxon
Rank tests were used to assess differences between
groups for each of the calculated kinematic parameter.
For the SS condition, parameters obtained from both
gait trials were averaged per subject. Significance level
was set at a = 0.05 for all analyses. We did not correct
the p values for multiple comparisons, as this is an
explorative study and we were concerned about pos-
sible Type II errors. However, instead of selecting
some of the results with specific p values, we avoided
any p hacking and reported all significant as well as
non-significant results to allow interpretation based on
the pattern of results.
The percentage of difference in average parameters
between both groups was calculated relative to the









Step LastStep Pre-lastFrom acousc signal     
to “start of 
movement”
Step 3Step 2
From acousc signal    
to first heel-strike
Gait phase between “start” and “end of movement”
Step Middle
FIGURE 2. Typical example of forward velocity signal (in AP direction), forward displacement signal, acceleration signals in the
three axes and angular velocity signals in the three planes from a subject with Parkinson’s disease.
Is the Assessment of 5 Meters of Gait with a Single Body-Fixed-Sensor
different parameters, sensitivity and specificity were
calculated by choosing the best classification threshold.
In addition, the harmonic mean of sensitivity and
specificity (F1) was calculated.
A stepwise discriminant analysis was separately
performed for the outcomes of the SS condition and
the outcomes of the FS condition, using Statistical
Package for the Social Sciences (SPSS), version 22.
First, significantly different parameters between groups
were preselected. Then, the correlations between these
were calculated (see Appendix 3 of supplementary
material). Next, from the preselected parameters, the
non-normally distributed were excluded. Moreover, in
case of absolute correlations above 0.7 between
parameters, the one with the highest p value in the test
for difference between groups was also excluded.
Subsequently, the remaining parameters (see Appendix
3 of supplementary material) were inserted in a for-
ward stepwise discriminant analysis. The sensitivity
and specificity of the model were additionally calcu-
lated by a 10-fold cross-validated discriminant analy-
sis.
RESULTS
Based on visual inspection, the proposed algorithm
detected all the steps/strides without false positives and
without false negatives when applied respectively on
both low-back accelerometry and heel accelerometry.
Absolute average differences in stride duration within
trials and across subjects between methods were on
average 31.1 ± 5.4 ms (5.4 ± 2.4% of average step
duration and ICC = 0.87).
For the phase delimited between the ‘‘start’’ and
‘‘end of movement’’, there were no significant differ-
ences between groups in number of steps (p = 0.95 for
SS condition, p = 0.17 for FS condition), nor in
average gait speed (p = 0.42 for both, SS and FS
condition). Table 2 (SS condition) and Table 3 (FS
condition) present, for all kinematic parameters, the
percentage difference between averaged values of both
groups and the p values of tests for differences between
groups. Further details regarding the correlations
between all significantly different parameters between
groups, and the mean and standard deviation of all
TABLE 2. Results of kinematic parameters for the self-selected gait speed condition (SS). The top number in each cell is the mean
percentage of differences, calculated as the mean value for outcomes from PDg minus mean value for outcomes from the HCg,
relative to the mean value for outcomes from the HCg. The bottom number is the corresponding p value for the difference (all
parameters with p < 0.05 are marked with a grey background). Note that the results corresponding to kinematic parameters relative
to the mean value across steps are marked with *R.
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parameters can be found in Appendices 3 and 4,
respectively.
In both conditions, most of the significantly differ-
ent kinematic parameters between groups were found
at initial gait phases (17 out of 31 and 5 out of 16
significant differences for the SS and FS condition,
respectively). Furthermore, in the SS condition, most
of the significant differences were found for kinematic
parameters expressed relative to the mean across steps
(19 out of 31 significant differences). For both condi-
tions, the largest number of kinematic parameters that
were significantly different between groups was found
for duration (6 gait phases in the SS condition and 4
gait phases in the FS condition) and RMS of angular
velocity around the AP axis (7 gait phases in the SS
and 4 gait phases in the FS condition). In the case of
FS condition, also 4 gait phases were significantly
different between groups for the RMS of angular
velocity around the ML axis. Notice that some of the
mentioned parameters were not independent from each
other (see Appendix 3 of supplementary material).
Percentages difference between groups under the SS
condition show that the PDg required a longer time
than the HCg to initiate the movement. However, the
middle step, pre-last step and mean duration across
steps were shorter in the PDg. In the FS condition, a
comparable reduced duration at intermediate and final
steps was found for the PDg, whereas no differences
with the HCg were found at gait initiation.
In both conditions (SS and FS), the PDg had an
increased sway around the AP axis (relative to the HCg) at
the phase delimited between the ‘‘start’’ and ‘‘end of
movement’’ and at themiddle step. This was evidenced by a
higherRMSof angular velocity around theAPaxis (Fig. 3;
Tables 3 and 4 from Appendix 4 of supplementary mate-
rial). Conversely, relative values of this feature at initial gait
phases were lower in the PDg than in the HCg (Fig. 4).
F1 scores ranged between 0.63 and 0.69 for parame-
ters of SS condition, and between 0.64 and 0.66 for
parameters of FS condition. The highest F1 score (0.69)
in the SS condition was found for the relative RMS of
angular velocity around the AP axis at the start of
movement (between the acoustic signal and the ‘‘start of
movement’’, and expressed relative to the mean across
steps). The highest F1 score (0.66) in the FS condition
was found for the duration of the middle step.
TABLE 3. Results of kinematic parameters for the fast gait speed condition (FS). The top number in each cell is the mean
percentage of differences, calculated as the mean value for outcomes from PDg minus mean value for outcomes from the HCg,
relative to the mean value for outcomes from the HCg. The bottom number is the corresponding p value for the difference (all
parameters with p < 0.05 are marked with a grey background). Note that the results corresponding to kinematic parameters relative
to the mean value across steps are marked with *R.
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From the stepwise discriminant analysis applied
with variables calculated from the SS condition, we
obtained 4 predictors: relative RMS of VT accelera-
tion at the second step, relative displacement at the
start of movement, range of AP velocity at the pre-
last step and relative RMS of VT acceleration at the
pre-last step. The discriminant function significantly
differentiated the groups (K = 0.39, Ӽ2 (2) = 32.09,
p< 0.001). A total of 92.1% of participants were
correctly classified; the sensitivity of the predictive
model was 100% and the specificity 78.6%. With the
10-fold cross-validated discriminant analysis, 89.5%
participants were correctly classified; the sensitivity
decreased to 95.8% and the specificity remained at
78.6%.
From the stepwise discriminant analysis applied
with variables calculated from the FS condition, we
obtained 2 predictors: duration of the middle step
and RMS of angular velocity around ML axis of the
last step. The discriminant function significantly dif-
ferentiated the groups (K = 0.61, Ӽ2 (2) = 16.78,
p< 0.001). A total of 81.6% of original grouped cases
were correctly classified; the sensitivity of the predic-
tive model was 87.5% and the specificity 71.4%. The
same results were found from the 10-fold cross-vali-
dated discriminant analysis.
FIGURE 3. Absolute values of RMS of Angular Velocity around AP axis for each gait phase. The error bars correspond to the
standard deviation of the outcomes from each group.
FIGURE 4. Values of RMS of Angular Velocity around AP axis for each gait phase, relative to the mean value across steps. The
error bars correspond to the standard deviation of the outcomes from each group.
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DISCUSSION
Based on the assessment of only 5 meters of gait
with a single BFS placed on the lower back, this study
presents a method for the identification of step-by-step
kinematic parameters in HCs and in patients at early-
to-moderate stages of idiopathic PD. Significant dif-
ferences between groups were found for certain
parameters, enhancing the understanding of gait
impairments in PD. Moreover, a selected number of
these parameters permitted to classify idiopathic PD-
associated gait with reasonable precision.
Gait Segmentation
The proposed algorithm segmented gait episodes in
step cycles with lower accuracy (p< 0.01) for the PDg
than for previously reported results from a HC cohort
(with differences of 3.4% in average step duration).11
This is possibly due to an asymmetrical and variable
gait and maybe due to pathological step initiation,
common in patients with idiopathic PD.3,10 We have
performed a post-hoc analysis, comparing all the esti-
mates when excluding the first event and we obtained a
lower (p = 0.01) absolute average difference:
21.1 ± 12.6 ms (3.7 ± 2.2% of average step duration
and ICC = 0.93). This indicates a lower accuracy on
the detection of the first event, possibly due to the
different nature of the acceleration signals along the
first step with respect to the other steps.
The obtained results were comparable to reported22
differences in step cycles between estimates from
accelerometry and gold standard methods in a PDg.
This implies that this method is also appropriate for
the analysis of gait in patients with idiopathic PD at
early-to-moderate stages.
Gait Initiation
Several studies3,10 have shown that patients with PD
often present impairments in anticipatory postural
adjustments and consequent difficulties in step initia-
tion, suggesting that the calculation of parameters over
initial gait phases is of special clinical interest in the
study of gait in PD. Indeed, most of the significantly
different parameters between groups of this study were
derived from initial gait phases. Particularly, under SS
condition, the PDg initiated stepping with longer
duration than the HCg. This, in agreement with other
studies, showed that movement latency was longer12
and step preparation was slower2,20 in the PDg. Pro-
longed duration at initial gait phases in the PDg imply
delays in reaction time and/or delays in gait initiation.
These delays might also contribute to lower RMS of
acceleration and angular velocity signals, since longer
static periods prior to gait initiation lead to lower
RMS values over these intervals. These findings are
also consistent with larger displacement at the time
that 30% of maximal AP velocity is reached, which
might reflect in a more pronounced bending from the
trunk in the PDg. Combined, these results suggest that
decreased values of signal fluctuations at initial gait
phases are not only related to delays in movement
initiation, but also to changes in kinematics.
Lower values for the PDg in RMS of acceleration
and angular velocity signals at gait initiation, relative
to the mean across steps, might also reflect impair-
ments in step preparation2,20 and impaired anticipa-
tory postural adjustments,12 particularly in the SS
condition. These problems might be due to a primary
balance deficit: the inability to properly shift weight to
one leg, normally required for contralateral limb
swing.3 Note however that relative rather than abso-
lute RMS values of acceleration and angular velocities
were affected, which might indicate that an increased
sway post-initiation of gait, rather than reduced sway
during initiation itself, may contribute to these differ-
ences. We speculate that these findings indicate a more
stiff movement in the PDg than in the HCg, possibly
due to reduced intersegmental articulation,19 increased
axial rigidity23 and impaired control over pelvis rota-
tion.25 Earlier work23 observed in-phase movements
between pelvis and thorax in patients with PD at self-
selected speed, whereas out-of-phase movements were
observed in control subjects; suggesting that the
assessed PDg had different trunk coordination from
the HCg.
Post-initiation of Gait
Shortened step duration is often seen in patients
with PD,20 possibly as a consequence of trunk rigid-
ity23 or reduced lower-extremity extension-flexion
movements.19 Accordingly, intermediate, pre-last steps
and mean values across steps were of shorter duration
in the PDg under both conditions (SS and FS). How-
ever, step length was not as clearly affected as step
duration. This could be related to errors in the calcu-
lation of step displacement inherent to the integration
drift. Nevertheless, under the SS condition, the dis-
placement of the second step relative to the mean
across steps was significantly reduced for the PDg. This
indicates that while the displacement right after gait
initiation seems not to be affected, increases in dis-
placement from the second step to the rest of steps
were more pronounced for individuals with PD than
for HCs.
The regulation of stride length, not the regulation of
step timing, is considered the central motor disruption
in gait hypokinesia and requires an increase in cadence
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as a compensatory mechanism.13 This was not present
in our results as the number of steps within the phase
delimited by the ‘‘start’’ and ‘‘end of movement’’ was
not significantly different between groups. Lack of
significant differences between groups in number of
steps, displacement, duration and average gait speed
calculated for the phase between the ‘‘start’’ and ‘‘end
of movement’’ might be due to the lack of consistency
in the duration of this phase across subjects of the
same group. Another potential reason for this could
have been the exclusion of the complete acceleration
and deceleration gait phases for the calculation of the
mentioned features. Especially the acceleration phase
took longer and, more importantly, the distance cov-
ered before the ‘‘start of movement’’ was 50% larger in
patients with PD. Differences may also have gone
unnoticed due to the short length of the walking track.
It has been shown14 that older adults change their
walking strategy as a function of walking distance.
This suggests that not only the PDg, but also the HCg
could have performed gait over 5 meters with different
strategies than in most of the studies based on longer,
and thus more steady gait protocols.
The RMS of angular velocity around the AP axis is
related to lateral sway and was sensitive to differences
between groups, not only as a mean value across steps,
but also at intermediate gait phases. Larger values of
this feature in the PDg at intermediate gait phases
suggest that once the propulsion in locomotion is
achieved, the frontal plane rotational velocity in sub-
jects with PD fluctuates more than in HCs, which
might reflect difficulties in the PDg to laterally control
the movement.20
Deceleration Phase in Gait
The assessment of the final gait phases is clinically
interesting since the ability to stop forward progression
of the body’s center of mass15 and the maintenance of
balance16 are challenged at gait termination. More-
over, patients with PD perform decelerating gait pha-
ses with altered strategies.15 This is reflected in our
study at the pre-last and last steps prior to the drop of
AP velocity. In the SS condition, individuals with PD
performed the pre-last step with decreased range of AP
velocity; suggesting that this group may have prepared
the end of locomotion by reducing movement intensity
differently from the HCg. Furthermore, larger fluctu-
ations in the PDg for the angular velocity around AP
axis (SS condition) and around ML axis (FS condition)
along the last two steps indicate difficulties in patients
with PD to maintain balance while stopping. Addi-
tionally, larger values of the displacement at the last
step relative to the mean across steps were obtained for
the PDg. This indicates that the PDg covered longer
distances per step (than the HCg) towards the end of
the gait trial.
Sensitivity of Kinematic Parameters
Most of the significantly different parameters
between groups and the lowest p values were obtained
for relative values with respect to the mean across
steps, being most of them independent from each
other. This suggests that the segmentation in step cy-
cles of short episodes of gait and the extraction of
features within these phases, additionally to the
extraction of mean features across steps, permits the
identification of PD sensitive parameters.
All the kinematic parameters that differed between
HC and PD subjects had a similar classification power,
indicated by similar F1 scores. However, from the re-
sults of the discriminant analysis we observe that the
combination of several parameters considerably (about
20%) increases the classification power of the model.
This is comparable to the classification power of
methods based on the assessment of 10-m gait with feet
accelerometry.1
In the final statistical models, half of the predictors
were based on RMS values, which suggests that fluc-
tuations of acceleration and angular velocity signals
are appropriate features to assess from short episodes
of gait for the recognition of idiopathic PD-associated
gait. The remaining predictors for the SS model (rel-
ative displacement at the start of movement and range
of AP velocity at the pre-last step) and for the FS
model (duration of the last step) indicate that spatio-
temporal information form initiation and ending of
gait is also relevant and complementary to discriminate
PD patterns from HCs.
Previous studies have shown that gait and balance
functions are relatively well conserved in self-selected
(or convenient) assessment conditions,17 whereas sub-
tle deficits are revealed in subjects with PD under more
challenging conditions.9,24 Conversely, our findings
indicate that the analysis with the proposed method of
short episodes of gait in SS condition permits a better
recognition of idiopathic PD-associated gait (from
patients at early-to-moderate stages) than in FS con-
dition. This is clinically relevant, since the assessment
of gait in SS condition is more feasible than in the FS
condition when physical limitations in some patients
impede performance of fast gait and/or this becomes a
burden for the participants. Note that in the present
study only one trial was performed for the FS condi-
tion (to limit the burden for the participants) against
two trials for the SS condition, which may have af-
fected the discriminant power of the FS condition.
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Applicability and Usefulness of this Method
Impairment in ambulation and lower-limb motor
planning are the main determinants of falls in patients
with PD. Particularly, deficits in anticipatory postural
adjustments cause gait akinesia and could lead to dif-
ficulties initiating a compensatory step, which is crucial
in balance correcting strategies to prevent patients
from falling.2 In this regard, the analysis of initial gait
phases, as proposed in this study, may be relevant in
the evaluation of risk of falling and the effect of
dopaminergic therapies.3 On the other hand, the
analysis of spatio-temporal outcomes extracted from
short episodes of gait such as gait speed, step timing
and step length might be useful as early markers of the
disease; reflecting the decline of motor automaticity
and bilateral motor control of gait.28
The use of BFS in the assessment of such short
episodes of gait adds a significant value compared to
the use of stopwatch measurements such as total
duration or gait speed. It permits to include step-by-
step analysis of several features which are sensitive to
PD and whose calculation does not rely on manual
marking.
Altogether, the quantitative assessment of short (5-
m) walking distances with this novel method may
contribute to the understanding of gait impairments in
a clinical setting. However, future work should com-
pare the proposed outcomes to more common clinical
assessments, such as the UPDRS and the SPPB, in
order to test the clinical value of the proposed tech-
nique.
Limitations
Several limitations of this study must be mentioned.
First, our findings cannot be generalized to the overall
PD population, since patients with PD and relevant
cognitive impairment were excluded. However, the fo-
cus of this study was on the assessment of parameters
related to gait motor symptoms of patients at early-to-
moderate stages of idiopathic PD. Second, while the
main objective of this study was to explore differences
in features of short gait episodes between groups in
order to recognize PD-associated gait, the reliability
and robustness of the parameters still need to be tested.
Third, short episodes of gait lack of steady-state phase
and present a limited number of cycles. Therefore,
kinematic parameters of important clinical value such
as gait variability, gait symmetry and local dynamic
stability are neither valid, nor reliable when estimated
from such data. Fourth, step cycles were delimited by
events that were defined as the instants of maximal
matching between the template and the signal. Thus,
the segmentation in step cycles based on a template-
matching algorithm depends on the selection of a
specific template (obtained as an average of gait cycles
from an individual gait trial) and the selected gait event
can slightly vary between subjects. But using the same
criteria for each of the subjects, these events approxi-
mately correspond to heel-strike events and the peri-
odicity of step cycles is obtained with
acceptable accuracy. On the other hand, while a gold
standard was not available, the accuracy of step
detection was tested by comparing estimates from heel
accelerometry. This was considered adequate for the
purpose because of the magnitude of the heel-strike
peaks in heel acceleration signals and the proximity of
the sensor to the location where the ground reaction
force impacts.11 Additionally, based on this method,
low accuracy in the detection of the first and the last
steps was expected. Consequently, the first heel-strike
was separately calculated to define the phase between
the acoustic signal and the first heel-strike. Moreover,
the last heel-strike was not included in the analysis,
since the ‘‘end of movement’’ was defined at the last
drop of velocity, prior to the last and positioning step.
Finally, the sample size of this cross-sectional study
(with relative lower size for the HCg than for the PDg)
might have resulted in limited statistical power. Thus,
this study should be considered as an explorative study,
albeit that previous publications related to gait assess-
ment in PD used comparable group size populations.1,5
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